InvestorsHub Logo
Followers 24
Posts 511
Boards Moderated 0
Alias Born 07/29/2015

Re: None

Monday, 08/14/2017 2:33:36 PM

Monday, August 14, 2017 2:33:36 PM

Post# of 463867
Anavex had a prior management team that was making progress in preclinical trials and in preparing for clinical trials. They seemed competent in every way but one: They ran out of money.

Tom Skarpelos, a co-founder and the largest shareholder, took over and started working on new funding. He hired Dr. Missling. Dr. Missling, backed by Skarpelos, has made sure we have not run out of money again, and are continuing to make progress in clinical trials.

I am satisfied and confident.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News